Vimarsana
Biggest News Aggregation in the World

Page 4 - Nasdaq Huma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Huma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Huma Today - Breaking & Trending Today

Cantor Fitzgerald Reiterates "Overweight" Rating for Humacyte (NASDAQ:HUMA) - Vimarsana News

Cantor Fitzgerald Reiterates "Overweight" Rating for Humacyte (NASDAQ:HUMA)

Cantor Fitzgerald reaffirmed their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $6.00 price objective on the stock. Several other brokerages have also recently weighed in on HUMA. Benchmark reiterated a buy rating and issued a […]

Humacyte (NASDAQ:HUMA) Earns "Overweight" Rating from Cantor Fitzgerald - Vimarsana News

Humacyte (NASDAQ:HUMA) Earns "Overweight" Rating from Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $6.00 target price on the stock. A number of other analysts have also weighed in on HUMA. Benchmark reaffirmed a buy rating and issued a […]

Source: wkrb13.com
Humacyte's (HUMA) "Overweight" Rating Reiterated at Cantor Fitzgerald - Vimarsana News

Humacyte's (HUMA) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. The brokerage currently has a $6.00 target price on the stock. A number of other research analysts also recently weighed in on HUMA. Piper Sandler raised Humacyte from an […]

Humacyte (NASDAQ:HUMA) Receives Overweight Rating from Cantor Fitzgerald - Vimarsana News

Humacyte (NASDAQ:HUMA) Receives Overweight Rating from Cantor Fitzgerald

Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They currently have a $6.00 price target on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 68.07% from the company’s previous close. Other […]

Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 602,443 Shares - Vimarsana News

Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 602,443 Shares

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) CEO Laura E. Niklason sold 602,443 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $3.39, for a total transaction of $2,042,281.77. Following the sale, the chief executive officer now directly owns 8,191,140 shares of […]